Journal
CANCERS
Volume 14, Issue 15, Pages -Publisher
MDPI
DOI: 10.3390/cancers14153762
Keywords
-
Categories
Funding
- Breast Cancer Research Foundation
- Bristol-Myers Squib [CW3199227]
Ask authors/readers for more resources
The article introduces a new training and proficiency program to improve pathologists' ability to score tumor infiltrating lymphocytes, and hence enhance the assessment of treatment response and prognosis.
Simple Summary New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimates of response to therapy and prognosis. Herewith, we propose a new training and proficiency program in which each pathologist can train and test themselves regarding TILs (and PDL1) scoring.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available